Annual EBITDA
-$60.72 M
-$52.56 M-644.28%
December 31, 2023
Summary
- As of February 8, 2025, ORGS annual EBITDA is -$60.72 million, with the most recent change of -$52.56 million (-644.28%) on December 31, 2023.
- During the last 3 years, ORGS annual EBITDA has risen by +$33.33 million (+35.44%).
- ORGS annual EBITDA is now -1734700.00% below its all-time high of -$3500.00, reached on November 30, 2008.
Performance
ORGS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$7.66 M
+$353.00 K+4.40%
September 30, 2024
Summary
- As of February 8, 2025, ORGS quarterly EBITDA is -$7.66 million, with the most recent change of +$353.00 thousand (+4.40%) on September 30, 2024.
- Over the past year, ORGS quarterly EBITDA has dropped by -$1.52 million (-24.74%).
- ORGS quarterly EBITDA is now -1131.36% below its all-time high of $743.00 thousand, reached on February 29, 2016.
Performance
ORGS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$30.63 M
-$5.13 M-20.14%
September 30, 2024
Summary
- As of February 8, 2025, ORGS TTM EBITDA is -$30.63 million, with the most recent change of -$5.13 million (-20.14%) on September 30, 2024.
- Over the past year, ORGS TTM EBITDA has increased by +$30.09 million (+49.56%).
- ORGS TTM EBITDA is now -1801547.06% below its all-time high of -$1700.00, reached on February 28, 2009.
Performance
ORGS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ORGS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -644.3% | -24.7% | +49.6% |
| 3 y3 years | +35.4% | -24.7% | +49.6% |
| 5 y5 years | -390.1% | +15.5% | +31.5% |
ORGS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -644.3% | at low | -2779.4% | +74.4% | -275.4% | +49.6% |
| 5 y | 5-year | -644.3% | +35.4% | -1521.7% | +85.3% | -275.4% | +67.4% |
| alltime | all time | <-9999.0% | +35.4% | -1131.4% | +85.3% | <-9999.0% | +67.4% |
Orgenesis EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.66 M(-4.4%) | -$30.63 M(+20.1%) |
| Jun 2024 | - | -$8.02 M(-9.0%) | -$25.49 M(-46.2%) |
| Mar 2024 | - | -$8.81 M(+43.4%) | -$47.39 M(-22.0%) |
| Dec 2023 | -$60.72 M(+644.3%) | -$6.14 M(+142.9%) | -$60.72 M(+11.8%) |
| Sep 2023 | - | -$2.53 M(-91.5%) | -$54.29 M(+4.3%) |
| Jun 2023 | - | -$29.91 M(+35.1%) | -$52.07 M(+93.6%) |
| Mar 2023 | - | -$22.14 M(-7840.6%) | -$26.90 M(+229.7%) |
| Dec 2022 | -$8.16 M(-46.1%) | $286.00 K(-193.5%) | -$8.16 M(-36.1%) |
| Sep 2022 | - | -$306.00 K(-93.5%) | -$12.77 M(-41.5%) |
| Jun 2022 | - | -$4.74 M(+39.6%) | -$21.83 M(+14.4%) |
| Mar 2022 | - | -$3.40 M(-21.5%) | -$19.08 M(+26.0%) |
| Dec 2021 | -$15.14 M(-83.9%) | -$4.33 M(-53.8%) | -$15.14 M(-76.0%) |
| Sep 2021 | - | -$9.36 M(+370.8%) | -$63.10 M(+0.5%) |
| Jun 2021 | - | -$1.99 M(-469.0%) | -$62.80 M(-28.1%) |
| Mar 2021 | - | $539.00 K(-101.0%) | -$87.36 M(-7.1%) |
| Dec 2020 | -$94.05 M(+408.0%) | -$52.28 M(+476.4%) | -$94.05 M(+110.3%) |
| Sep 2020 | - | -$9.07 M(-65.8%) | -$44.72 M(+13.3%) |
| Jun 2020 | - | -$26.55 M(+331.9%) | -$39.48 M(+134.3%) |
| Mar 2020 | - | -$6.15 M(+107.6%) | -$16.85 M(-7.1%) |
| Dec 2019 | -$18.51 M(+49.4%) | -$2.96 M(-22.7%) | -$18.14 M(-16.8%) |
| Sep 2019 | - | -$3.83 M(-2.1%) | -$21.79 M(+13.5%) |
| Jun 2019 | - | -$3.91 M(-47.3%) | -$19.20 M(+11.5%) |
| Mar 2019 | - | -$7.43 M(+12.4%) | -$17.21 M(+37.3%) |
| Nov 2018 | -$12.39 M(+25.8%) | -$6.61 M(+433.8%) | -$12.54 M(+90.9%) |
| Aug 2018 | - | -$1.24 M(-35.8%) | -$6.57 M(-16.6%) |
| May 2018 | - | -$1.93 M(-29.9%) | -$7.88 M(-1.3%) |
| Feb 2018 | - | -$2.75 M(+328.5%) | -$7.98 M(-18.9%) |
| Nov 2017 | -$9.85 M(+8.8%) | -$643.00 K(-74.8%) | -$9.84 M(-24.0%) |
| Aug 2017 | - | -$2.55 M(+25.6%) | -$12.95 M(+2.1%) |
| May 2017 | - | -$2.03 M(-56.0%) | -$12.69 M(-11.4%) |
| Feb 2017 | - | -$4.62 M(+23.2%) | -$14.31 M(+59.9%) |
| Nov 2016 | -$9.05 M | -$3.75 M(+63.8%) | -$8.95 M(+49.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2016 | - | -$2.29 M(-37.4%) | -$6.00 M(+31.1%) |
| May 2016 | - | -$3.66 M(-592.3%) | -$4.58 M(+263.8%) |
| Feb 2016 | - | $743.00 K(-192.9%) | -$1.26 M(-52.9%) |
| Nov 2015 | -$2.67 M(-44.4%) | -$800.00 K(-7.5%) | -$2.67 M(+116.6%) |
| Aug 2015 | - | -$865.00 K(+156.7%) | -$1.24 M(-65.5%) |
| May 2015 | - | -$337.00 K(-49.9%) | -$3.58 M(-25.1%) |
| Feb 2015 | - | -$673.00 K(-205.2%) | -$4.78 M(-0.6%) |
| Nov 2014 | -$4.81 M(-10.4%) | $639.80 K(-119.9%) | -$4.81 M(-33.2%) |
| Aug 2014 | - | -$3.21 M(+109.1%) | -$7.20 M(+46.3%) |
| May 2014 | - | -$1.54 M(+118.8%) | -$4.92 M(+0.7%) |
| Feb 2014 | - | -$701.70 K(-59.9%) | -$4.89 M(-11.2%) |
| Nov 2013 | -$5.36 M(+7.5%) | -$1.75 M(+88.1%) | -$5.51 M(+7.4%) |
| Aug 2013 | - | -$931.40 K(-38.1%) | -$5.12 M(-15.7%) |
| May 2013 | - | -$1.50 M(+13.9%) | -$6.08 M(+11.5%) |
| Feb 2013 | - | -$1.32 M(-3.7%) | -$5.45 M(+9.3%) |
| Nov 2012 | -$4.99 M(+6788.4%) | -$1.37 M(-27.4%) | -$4.99 M(+35.6%) |
| Aug 2012 | - | -$1.89 M(+116.0%) | -$3.68 M(+105.2%) |
| May 2012 | - | -$874.50 K(+2.4%) | -$1.79 M(+94.7%) |
| Feb 2012 | - | -$853.80 K(+1279.3%) | -$920.70 K(+1173.4%) |
| Nov 2011 | -$72.40 K(+241.5%) | -$61.90 K(+2192.6%) | -$72.30 K(+292.9%) |
| Aug 2011 | - | -$2700.00(+17.4%) | -$18.40 K(-13.2%) |
| May 2011 | - | -$2300.00(-57.4%) | -$21.20 K(-10.9%) |
| Feb 2011 | - | -$5400.00(-32.5%) | -$23.80 K(+12.3%) |
| Nov 2010 | -$21.20 K(-17.2%) | -$8000.00(+45.5%) | -$21.20 K(+15.8%) |
| Aug 2010 | - | -$5500.00(+12.2%) | -$18.30 K(-30.2%) |
| May 2010 | - | -$4900.00(+75.0%) | -$26.20 K(-2.2%) |
| Feb 2010 | - | -$2800.00(-45.1%) | -$26.80 K(+4.3%) |
| Nov 2009 | -$25.60 K(+631.4%) | -$5100.00(-61.9%) | -$25.70 K(+24.8%) |
| Aug 2009 | - | -$13.40 K(+143.6%) | -$20.60 K(+186.1%) |
| May 2009 | - | -$5500.00(+223.5%) | -$7200.00(+323.5%) |
| Feb 2009 | - | -$1700.00 | -$1700.00 |
| Nov 2008 | -$3500.00 | - | - |
FAQ
- What is Orgenesis annual EBITDA?
- What is the all time high annual EBITDA for Orgenesis?
- What is Orgenesis annual EBITDA year-on-year change?
- What is Orgenesis quarterly EBITDA?
- What is the all time high quarterly EBITDA for Orgenesis?
- What is Orgenesis quarterly EBITDA year-on-year change?
- What is Orgenesis TTM EBITDA?
- What is the all time high TTM EBITDA for Orgenesis?
- What is Orgenesis TTM EBITDA year-on-year change?
What is Orgenesis annual EBITDA?
The current annual EBITDA of ORGS is -$60.72 M
What is the all time high annual EBITDA for Orgenesis?
Orgenesis all-time high annual EBITDA is -$3500.00
What is Orgenesis annual EBITDA year-on-year change?
Over the past year, ORGS annual EBITDA has changed by -$52.56 M (-644.28%)
What is Orgenesis quarterly EBITDA?
The current quarterly EBITDA of ORGS is -$7.66 M
What is the all time high quarterly EBITDA for Orgenesis?
Orgenesis all-time high quarterly EBITDA is $743.00 K
What is Orgenesis quarterly EBITDA year-on-year change?
Over the past year, ORGS quarterly EBITDA has changed by -$1.52 M (-24.74%)
What is Orgenesis TTM EBITDA?
The current TTM EBITDA of ORGS is -$30.63 M
What is the all time high TTM EBITDA for Orgenesis?
Orgenesis all-time high TTM EBITDA is -$1700.00
What is Orgenesis TTM EBITDA year-on-year change?
Over the past year, ORGS TTM EBITDA has changed by +$30.09 M (+49.56%)